Moderna (MRNA) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted an opinion recommending marketing authorization for an updated formulation of ...

Moderna (MRNA) nnounced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion recommending marketing authorization for an updated ...

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Exelixis. The consensus rating ...

The finance professor and quant investing veteran believes with the right guardrails, artificial intelligence could be trusted to meet the high bar of fiduciary advice.

EUR/USD is still under slight negative pressure, trading above the 1.1700 hurdle and adding to Thursday's decline. Meanwhile, ...

In this week’s edition of The Prototype, we look at a quantum computing milestone for biotech, a new way to get forever ...

A Turkish study finds Pfizer’s COVID-19 vaccine may cause temporary changes in corneal thickness and cell count, raising concerns for those with existing eye issues or transplants.

The race to develop effective cancer vaccines has entered a new phase, with late-stage trials from companies like Moderna ...

BioMarin Pharmaceuticals is one of many biotech companies that’s laid off workers over the past two years. Its office in ...

Get the 2025 update on the biotech companies Labiotech spotlighted in 2024 — who advanced, who stalled, and who surprised us.

A daily rundown of the economic reports and corporate earnings that will be grabbing the market’s attention in the week ahead ...

There’s still plenty of room for growth as the AI race continues to unfold. Still, some growth investors are already moving ...